Credit Suisse Ag Dyne Therapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 36,383 shares of DYN stock, worth $863,004. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,383

Previous 26,858 35.46%

Holding current value

$863,004

Previous $357,000 189.08%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$13.06 - $29.18 $124,396 - $277,939	9,525 Added 35.46%	36,383 $1.03 Million
Q4 2023 Feb 08, 2024	SELL	$6.62 - $13.64 $6,401 - $13,189	-967 Reduced 3.48%	26,858 $357,000
Q3 2023 Nov 13, 2023	SELL	$8.6 - $12.18 $50,069 - $70,911	-5,822 Reduced 17.3%	27,825 $249,000
Q2 2023 Aug 11, 2023	BUY	$8.53 - $14.28 $84,711 - $141,814	9,931 Added 41.87%	33,647 $378,000
Q1 2023 May 10, 2023	BUY	$10.88 - $15.0 $57,914 - $79,845	5,323 Added 28.94%	23,716 $273,000
Q4 2022 Feb 13, 2023	BUY	$9.37 - $13.8 $2,164 - $3,187	231 Added 1.27%	18,393 $213,000
Q3 2022 Nov 10, 2022	BUY	$7.2 - $15.17 $1,058 - $2,229	147 Added 0.82%	18,162 $231,000
Q2 2022 Aug 12, 2022	BUY	$4.36 - $10.5 $7,538 - $18,154	1,729 Added 10.62%	18,015 $124,000
Q1 2022 May 16, 2022	SELL	$6.52 - $12.27 $5,985 - $11,263	-918 Reduced 5.34%	16,286 $156,000
Q4 2021 Feb 14, 2022	BUY	$11.89 - $16.07 $35,931 - $48,563	3,022 Added 21.31%	17,204 $204,000
Q3 2021 Nov 12, 2021	BUY	$15.6 - $21.46 $49,545 - $68,156	3,176 Added 28.86%	14,182 $230,000
Q2 2021 Aug 16, 2021	SELL	$15.94 - $22.33 $1.37 Million - $1.91 Million	-85,711 Reduced 88.62%	11,006 $231,000
Q1 2021 May 14, 2021	BUY	$14.0 - $29.3 $833,280 - $1.74 Million	59,520 Added 160.01%	96,717 $1.5 Million
Q4 2020 Feb 12, 2021	BUY	$16.81 - $23.94 $333,594 - $475,089	19,845 Added 114.37%	37,197 $781,000
Q3 2020 Nov 13, 2020	BUY	$20.0 - $23.9 $347,040 - $414,712	17,352 New	17,352 $350,000

Others Institutions Holding DYN

# of Institutions

209

Shares Held

102M

Call Options Held

234K

Put Options Held

238K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.23B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account